Search research articles
Contact Us
Filters
Showing results (321-330 of 373) with videos related to
Page
of 38
Sort By:
Ebiomedicine
|
May 18, 2019
Combination of apoptotic T cell induction and self-peptide administration for therapy of experimental autoimmune encephalomyelitis
Shimpei Kasagi, Dandan Wang, Pin Zhang, et al.
Blood
|
August 14, 2013
PARP-1 regulates expression of TGF-β receptors in T cells
Pin Zhang, Hiroko Nakatsukasa, Eric Tu, et al.
Cancer Biology & Medicine
|
September 13, 2024
Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2- advanced breast cancer
Qi Zhao, Mingxia Jiang, Jiaxuan Liu, et al.
Angewandte Chemie (International Ed. in English)
|
January 20, 2021
Chiral Spiro-Axis Induced Blue Thermally Activated Delayed Fluorescence Material for Efficient Circularly Polarized OLEDs with Low Efficiency Roll-Off
Yi-Pin Zhang, Xiao Liang, Xu-Feng Luo, et al.
Breast Cancer Research and Treatment
|
March 17, 2022
Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer
Yun Wu, Yiqun Han, Qing Li, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
January 12, 2026
Factors associated with neoadjuvant therapy insensitivity and its prognostic impact in HER2-positive breast cancer
Yuhang Han, Bo Lan, Zexi Peng, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 8, 2013
[Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer]
Wen-yue Ma, Pin Zhang, Bai-lin Zhang, et al.
Therapeutic Advances in Medical Oncology
|
January 5, 2026
Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world study
Xuenan Peng, Ruixia Song, Ying Fan, et al.
Heliyon
|
October 10, 2024
The different sequences of CDK4/6 inhibitor and mTOR inhibitor in HR+/HER2-advanced breast cancer: A multicenter real-world study
Yuqian Liao, Yujing Tan, Yipeng Li, et al.
Journal of Clinical Nursing
|
December 9, 2024
Prevalence of Frailty and Its Impact on Quality of Life in Older Patients With Breast Cancer: A Prospective Cross-Sectional Study
Min Xiao, Xi Chen, Lei Ji, et al.
Page
of 38
Search research articles
Search
Showing results (321-330 of 373) with videos related to
Sort By:
Page
of 38
Ebiomedicine
|
May 18, 2019
Combination of apoptotic T cell induction and self-peptide administration for therapy of experimental autoimmune encephalomyelitis
Shimpei Kasagi, Dandan Wang, Pin Zhang, et al.
Blood
|
August 14, 2013
PARP-1 regulates expression of TGF-β receptors in T cells
Pin Zhang, Hiroko Nakatsukasa, Eric Tu, et al.
Cancer Biology & Medicine
|
September 13, 2024
Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2- advanced breast cancer
Qi Zhao, Mingxia Jiang, Jiaxuan Liu, et al.
Angewandte Chemie (International Ed. in English)
|
January 20, 2021
Chiral Spiro-Axis Induced Blue Thermally Activated Delayed Fluorescence Material for Efficient Circularly Polarized OLEDs with Low Efficiency Roll-Off
Yi-Pin Zhang, Xiao Liang, Xu-Feng Luo, et al.
Breast Cancer Research and Treatment
|
March 17, 2022
Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer
Yun Wu, Yiqun Han, Qing Li, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
January 12, 2026
Factors associated with neoadjuvant therapy insensitivity and its prognostic impact in HER2-positive breast cancer
Yuhang Han, Bo Lan, Zexi Peng, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 8, 2013
[Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer]
Wen-yue Ma, Pin Zhang, Bai-lin Zhang, et al.
Therapeutic Advances in Medical Oncology
|
January 5, 2026
Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world study
Xuenan Peng, Ruixia Song, Ying Fan, et al.
Heliyon
|
October 10, 2024
The different sequences of CDK4/6 inhibitor and mTOR inhibitor in HR+/HER2-advanced breast cancer: A multicenter real-world study
Yuqian Liao, Yujing Tan, Yipeng Li, et al.
Journal of Clinical Nursing
|
December 9, 2024
Prevalence of Frailty and Its Impact on Quality of Life in Older Patients With Breast Cancer: A Prospective Cross-Sectional Study
Min Xiao, Xi Chen, Lei Ji, et al.
Page
of 38